FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by calculating the risk of the presence or absence of severe hepatic fibrosis in the patient.
EFFECT: method allows for an increase in the sensitivity, specificity and accuracy of the study.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
| METHOD OF HEPATIC FIBROSIS INVASIVE SEVERITY EVALUATION ACCOMPANIED WITH CHRONIC VIRAL HEPATITIS | 2006 |
|
RU2328744C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
| METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
| METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
| NONINVASIVE METHOD FOR DIAGNOSING HEPATIC FIBROSIS GRADE IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2261441C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| SCREENING DIAGNOSING METHOD FOR FATTY LIVER DEGENERATION ACCOMPANYING ABDOMINAL OBESITY | 2018 |
|
RU2684201C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
